Bryan Johnson, the anti-aging influencer, halted his Rapamycin regimen after five years due to adverse side effects like ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

A study led by two undergraduate students at the University of Galway found that GLP-1 receptor agonists, a type of diabetes ...

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...

New research further solidifies findings that aspirin could be a powerful anti-cancer drug, at least in some specific cases.

Dr. Evan Levine tackles a drug that is often prescribed to help children perform better — a phenomenon he calls “borderline ...

The Trump administration announced that it will not expand coverage for weight loss medication, GLP-1 drugs like Zepbound and ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

Major” tariffs on pharmaceutical imports are coming soon, President Donald Trump says, pledging that they’d help bring drug ...

Ketamine, a Class B drug, is a dissociative anaesthetic which is often used as a party drug but can cause serious health ...

The Biden administration had proposed late last year coverage of the popular medicines for obesity.